We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 31 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 30 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 29 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
ARDEE, Ireland, Dec. 15 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender...
ARDEE, Ireland, Nov. 19 /PRNewswire/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a...
ARDEE, Ireland, Oct. 30 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription...
ARDEE, Ireland and COPENHAGEN, Sept. 23 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion...
SemGroup LP, Skype Technologies and Warner Chilcott PLC (WCRX) are among companies selling billions of dollars of high-risk loans as the market shows tentative signs of recovery after lying...
SemGroup LP, Skype Technologies and Warner Chilcott PLC (WCRX) are among companies selling billions of dollars of high-risk loans as the market shows tentative signs of recovery after lying...
By Kate Gibson With health care a hotly debated topic on Capitol Hill and Wall Street for the foreseeable future, stock market observers on Thursday weighed the impact of possible reform on the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions